HCP Company Profile (NYSE:HCP)

HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."

HCP declared a quarterly dividend on Thursday, July 27th. Shareholders of record on Monday, August 7th will be paid a dividend of $0.37 per share on Tuesday, August 22nd. This represents a $1.48 dividend on an annualized basis and a yield of 4.64%. The ex-dividend date is Thursday, August 3rd. View HCP's Dividend History.

HCP, Inc. (NYSE:HCP) announced its quarterly earnings data on Tuesday, May, 2nd. The company reported $0.51 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.48 by $0.03. The business earned $492.16 million during the quarter, compared to analysts' expectations of $514.82 million. HCP had a return on equity of 12.39% and a net margin of 41.38%. HCP's revenue for the quarter was down 5.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.69 EPS. View HCP's Earnings History.

HCP issued an update on its FY17 earnings guidance on Tuesday, May, 2nd. The company provided earnings per share guidance of $1.89-1.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.93.

17 brokers have issued 12 month target prices for HCP's stock. Their predictions range from $30.00 to $38.00. On average, they anticipate HCP's share price to reach $32.69 in the next twelve months. View Analyst Ratings for HCP.

HCP saw a decline in short interest in the month of June. As of June 15th, there was short interest totalling 12,471,365 shares, a decline of 16.4% from the May 31st total of 14,923,619 shares. Based on an average trading volume of 3,017,762 shares, the short-interest ratio is presently 4.1 days. Currently, 2.7% of the shares of the stock are short sold.

Some companies that are related to HCP include Welltower (HCN), Ventas (VTR), Omega Healthcare Investors (OHI), Medical Properties Trust (MPW), Healthcare Trust of America (HTA), Healthcare Realty Trust Incorporated (HR), Physicians Realty Trust (DOC), National Health Investors (NHI), Care Capital Properties (CCP), LTC Properties (LTC), Sabra Healthcare REIT (SBRA), CareTrust REIT (CTRE), Assura PLC (AGR), Primary Health Properties PLC (PHP), MedEquities Realty Trust (MRT), Community Healthcare Trust Incorporated (CHCT), Aviv REIT (AVIV) and Global Medical REIT (GMRE).

HCP's management team includes the folowing people:

• Michael Dale McKee, Executive Chairman of the Board
• Thomas M. Herzog, Chief Executive Officer, Director
• Peter A. Scott, Chief Financial Officer, Executive Vice President
• Scott A. Anderson, Executive Vice President, Chief Accounting Officer
• Troy E. McHenry, Executive Vice President, General Counsel, Corporate Secretary
• Jonathan M. Bergschneider, Executive Vice President - Life Science Estates
• Thomas M. Klaritch CPA, Executive Vice President - Medical Office Properties
• Kendall K. Young, Executive Vice President - Senior Housing Investments
• Kai Hsiao, Senior Managing Director - Senior Housing Properties
• David B. Henry, Lead Independent Director

HCP's stock is owned by a number of of retail and institutional investors. Top institutional investors include PGGM Investments (1.21%), APG Asset Management US Inc. (0.74%), Russell Investments Group Ltd. (0.49%), Hexavest Inc. (0.44%), NN Investment Partners Holdings N.V. (0.23%) and LGT Capital Partners LTD. (0.16%). Company insiders that own HCP stock include Darren A Kowalske, James Justin Hutchens, James P Hoffmann, Jonathan M Bergschneider, Kai Hsiao, Kendall K Young, Lauralee Martin, Peter L Rhein, Scott A Anderson, Thomas D Kirby and Thomas Klaritch. View Institutional Ownership Trends for HCP.

HCP's stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Sumitomo Mitsui Asset Management Company LTD, APG Asset Management N.V., Strs Ohio, Hartford Investment Management Co., Nisa Investment Advisors LLC and Pensionfund DSM Netherlands. Company insiders that have sold HCP stock in the last year include Darren A Kowalske, Jonathan M Bergschneider, Kendall K Young, Scott A Anderson, Thomas D Kirby and Thomas Klaritch. View Insider Buying and Selling for HCP.

HCP's stock was bought by a variety of institutional investors in the last quarter, including APG Asset Management US Inc., Russell Investments Group Ltd., NN Investment Partners Holdings N.V., Real Estate Management Services LLC, Bank of Montreal Can, PGGM Investments, State of Alaska Department of Revenue and ING Groep NV. Company insiders that have bought HCP stock in the last two years include Darren A Kowalske, James Justin Hutchens, James P Hoffmann, Kendall K Young, Lauralee Martin and Thomas D Kirby. View Insider Buying and Selling for HCP.

Shares of HCP can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of HCP stock can currently be purchased for approximately $31.91.